Prince, Elisabeth
Cruickshank, Jennifer
Ba-Alawi, Wail http://orcid.org/0000-0002-2747-4703
Hodgson, Kelsey
Haight, Jillian
Tobin, Chantal
Wakeman, Andrew
Avoulov, Alona
Topolskaia, Valentina
Elliott, Mitchell J. http://orcid.org/0000-0001-6711-7287
McGuigan, Alison P. http://orcid.org/0000-0003-2803-0917
Berman, Hal K.
Haibe-Kains, Benjamin
Cescon, David W. http://orcid.org/0000-0002-1080-0998
Kumacheva, Eugenia http://orcid.org/0000-0001-5942-3890
Article History
Received: 31 August 2020
Accepted: 1 February 2022
First Online: 18 March 2022
Competing interests
: E.K. and E.P. have filed an International PCT patent application (Serial No. PCT/CA2018/050862, Filing Date: July 16, 2018). D.W.C has served as a consultant for Agendia, Dynamo Therapeutics, AstraZeneca, Eisai, Exact Sciences, Gilead, GSK, Merck, Novartis, Pfizer, Puma, Roche; receives research support (to institution) from GSK, Merck, Pfizer, Roche and Inivata and holds a patent (US62/675,228) for methods of treating cancers characterized by a high expression level of spindle and kinetochore associated complex subunit 3 (ska3) gene. There are no other competing interests.